Local deiodination of L-thyroxine (T 4 ) to the active thyroid hormone T 3 via two 5Јdeiodinase isoenzymes (5ЈDI and 5ЈDII) plays an important role for various T 3 -dependent functions of the anterior pituitary (AP). Recently, it was reported that 3,5-T2, the 5Јdeiodination product of T 3 , acts as a specific agonist in the feedback mechanism on TSH secretion at the pituitary level. We now examined the effects of 3,5-T2 on pituitary 5Јdeiodinase activities in vivo in male, adult rats and in vitro using rat AP reaggregate cultures and the somatomammotroph cell line GH3. 5ЈDI activity in the AP was transiently increased after a single injection of 3,5-T2. Serum TSH levels declined, and 24 h after 3,5-T2 application, ␤TSH steady-state mRNA levels in the APs were markedly lower. In reaggregate cultures of the AP, 3,5-T2 stimulated 5ЈDI activity 24 h after application, dose-dependently. Compared with 5ЈDI activities, those of 5ЈDII were an order of magnitude lower, in vivo as well as in vitro, and were rapidly and transiently decreased by the higher dose of 3,5-T2. GH3 cells responded to 3,5-T2 and T 3 by an 1.7-fold stimulation of 5ЈDI activity. Stimulation of DNA-binding was demonstrated in electrophoretic mobility shift assays for a specific RXR-containing protein complex with a DRϩ4 thyroid hormone response element of the human type 1 5ЈDI promoter using nuclear extracts from GH3 cells treated with 3,5-T2. In summary, 3,5-T2 and T 3 exert direct thyromimetic effects on 5ЈDI activity and TSH␤ expression at the pituitary level. 5ЈDI is regulated by its substrate(s) and/or products and may serve an important function within the modulation of thyroid hormone-dependent gene expression in the AP. (Endocrinology 138: 3242-3248, 1997) T HYROID hormones play an important role in various functions of the anterior pituitary (AP), e.g. TSH (1), GH (2, 3), and PRL (4, 5) gene expression. Most of the T 3 , the main active form of thyroid hormones, is generated by 5Ј-monodeiodination of l-thyroxine (T 4 ), the prohormone secreted by the thyroid gland. Two distinct 5Ј-deiodinase-isoenzymes (5ЈDI and 5ЈDII, which differ in reaction kinetics, substrate specificity, inhibitor sensitivity, and regulation) contribute to systemic and local formation of T 3 (6). In the pituitary gland of euthyroid rats, half of the T 3 bound to specific nuclear receptors is derived from local, intrapituitary T 4 -to-T 3 conversion via deiodinase isoenzymes (7). So far, no 5-deiodinase activity resulting in the formation of the presumably inactive metabolites, rT 3 and 3,3Ј-diiodothyronine, has been demonstrated in pituitary models.
T HYROID hormones play an important role in various
functions of the anterior pituitary (AP), e.g. TSH (1), GH (2, 3) , and PRL (4, 5) gene expression. Most of the T 3 , the main active form of thyroid hormones, is generated by 5Ј-monodeiodination of l-thyroxine (T 4 ), the prohormone secreted by the thyroid gland. Two distinct 5Ј-deiodinase-isoenzymes (5ЈDI and 5ЈDII, which differ in reaction kinetics, substrate specificity, inhibitor sensitivity, and regulation) contribute to systemic and local formation of T 3 (6) . In the pituitary gland of euthyroid rats, half of the T 3 bound to specific nuclear receptors is derived from local, intrapituitary T 4 -to-T 3 conversion via deiodinase isoenzymes (7) . So far, no 5-deiodinase activity resulting in the formation of the presumably inactive metabolites, rT 3 and 3,3Ј-diiodothyronine, has been demonstrated in pituitary models.
Recently, it was reported that 3,5-diiodothyronine (3, 5-T2), a naturally occurring metabolite of T 3 , not only exerts rapid, short-term effects on mitochondrial respiration (8 -11) , but also acts as a specific agonist in the feedback mechanism on TSH-secretion at the pituitary level without other apparent thyromimetic effects (12) .
Transcription of the TSH genes is suppressed by T 3 bound to the pituitary-specific thyroid hormone receptor TR␤ 2 (13) via negative T 3 response elements in the promoters of these genes. TR␤ 2 knock-out mice show phenotypes compatible with a predominant function of the TR␤ 2 receptor at the brain and the pituitary level (14, 15) . Alterations of pituitary-deiodinase activities, which themselves are regulated also by thyroid hormones (16, 17) , are involved in this negative TSH feedback mechanism. As 3,5-T2 exerts obvious T 3 -like effects on TSH secretion at the pituitary level, we evaluated whether 3,5-T2 also modulates pituitary deiodinase activities in vivo and in vitro using euthyroid male rats, rat AP reaggregates, and the somatomammotroph rat cell line GH3. For examination of pituitary functions, the reaggregated AP cells, which are cultured in serum-free, hormonally defined media, provide a more physiological model than monolayers, because the 3-dimensional, tissue-like organization favors cellto-cell communication and para/autocrine interactions between the different cell types of the AP (18) .
Animal treatment
Male adult Sprague-Dawley rats (6 months) were kept under standard housing conditions (12-h day/night cycle). They received a single injection of T 3 (100 g/kg BW), 3,5-T2 (800 g/kg or 1600 g/kg BW), or vehicle (15% dimethyl sulfoxide in 0.9% saline) ip between 0800 h and 0900 h and were killed by decapitation at the indicated time points. Blood was collected from every single animal for serum preparation; serum samples were stored at Ϫ80 C until use.
Preparation of pituitary homogenates
After decapitation, the pituitaries were removed, AP and posterior pituitary (including intermediate lobe) were separated, immediately frozen on dry ice blocks, and stored at Ϫ80 C until use. Single APs were homogenized by sonication (10 times, 0.5 sec, 300 watts) in 80 l ice-cold homogenization buffer (250 mm sucrose, 20 mm HEPES, 1 mm EDTA, 1 mm dithiothreitol, pH 7).
Reaggregate cultures of AP cells
Anterior pituitaries were removed from 20 adult male Cara rats and processed according to the protocol of Denef et al. (18) . After 2 days in culture, reaggregates from two 35-mm petri dishes were transferred to one 60-mm petri dish, and half of the serum-free medium was replaced by 2 vol fresh medium. Three days later, half of the medium was removed and substituted by fresh medium containing 3,5-T2 (final concentration 3 nm or 30 nm) or solvent (final concentration 1.25 m NaOH). After 48 h, the reaggregates were harvested, washed once with ice-cold PBS, and sonicated, as described above. The homogenates were stored at Ϫ20 C until further use.
Cell culture
GH3 cells (ATCC No. CCL. 82.1) were cultured in Ham's F10 medium supplemented with 15% horse serum, 2.5% FCS, and antibiotics (penicillin 10 U/ml, streptomycin 0.1 mg/ml). Three days after plating the cells on 25-cm 2 culture flasks, the medium was removed and replaced by fresh medium containing T 3 (final concentration 3 nm), 3,5-T2 (final concentration 3, 30, or 300 nm) or vehicle (final concentration 1.25 m NaOH). After 48 h incubation, the cells were harvested and sonicated, as described above.
Biochemical assays
Specific activities of type I and type II 5ЈD were determined in parallel by the release of 125 I Ϫ from 3,3Ј,5Ј-[ 125 I]-reverse T 3 (DuPont, Bad Homburg, Germany) in the absence or presence of 1 mm PTU (6-N-propyl-2-thio-uracil) using 10 nm nonradioactive rT 3 and 20 mm dithiothreitol (19, 17) . The fraction of iodide release blocked by 1 mm PTU was assigned to 5ЈDI; the residual activity not inhibited by PTU was ascribed to 5ЈDII. 5ЈD-activities of each sample were determined in triplicate and expressed as fmol 125 I Ϫ released per min per mg protein. The protein contents of the homogenates were determined by a modified Bradford (20) protein assay (Biorad, Munich, Germany) using ␥-globulin as protein standard.
Electrophoretic mobility shift assays (EMSAs)
GH3 cells were grown in 25-cm 2 culture flasks in Ham's F10 medium supplemented with 15% horse serum and 2.5% FCS for 3 days and then kept under serum-free conditions for 24 h before stimulation with T 3 (final concentration 3 nm) or 3,5-T2 (final concentration 3 nm or 30 nm) for 0.5 h, 1.5 h, or 24 h. At the indicated time points, nuclear cell extracts were prepared as described by Grandison et al. (21) . Protein concentrations of the nuclear extracts were determined as described above. Equal amounts of protein (6 g) were used for EMSAs. The oligonucleotide used was derived from the DRϩ4 element in the 5Јregulatory region of human 5ЈDI gene (22) , which represents an ideal DRϩ4 thyroid hormone response element (5Ј-CGGGTAGGTCATCTGAGGTCAGGAGT-3Ј). Oligonucleotides were labeled with [␥ 32 P]-ATP using T 4 polynucleotide kinase. Binding reactions were performed for 30 min at room temperature in reaction buffer described by Grandison et al. (21) . For each binding reaction, 20,000 cpm of labeled oligonucleotide were used. Supershifting was performed with anti-RXR antibody (kindly provided by Dr. P. Chambon).
Northern analysis
Total RNA was isolated and purified from pooled rat AP homogenates by centrifugation through CsCl gradient, as described by Chirgwin (23) (six pituitaries per data point). Fifteen micrograms of total RNA were separated by electrophoresis in a denaturing agarose gel (2.2 m formaldehyde, 1% agarose) and capillary transferred to a nylon membrane (Hybond, Amersham, Braunschweig, Germany). Hybridization was performed at high stringency in 50% formamide, 5ϫ sodium chloride, sodium dihydrogen phosphate, EDTA (0.9 m NaCl, 75 mm NaH 2 PO 4 , 7.5 mm EDTA, pH 7.4), 0.5% SDS, 5ϫ Denhardts (0.1% BSA, 0.1% ficoll, 0.1% polyvinylpyrrolidone), and 500 g denatured salmon sperm DNA in a final vol of 10 ml with a TSH␤-complementary RNA probe or 18S ribosomal RNA-complementary DNA (cDNA). Blots were washed in 1% SDS and decreasing concentrations of SSC (0.15 m NaCl, 15 mm sodium citrate Na 3 
Determination of TSH
TSH levels were determined by RIA according to the manufacturer's instructions (NIH, Bethesda, MD).
Statistical analysis
Data were analyzed by multiple ANOVA. When the main effect was significant, the U test of Mann and Whitney was applied as posthoc test to determine individual differences between means.
Results

Effects of 3,5-T2 on 5Јdeiodinase activities in the AP of male adult rats
In the AP of male rats, specific 5ЈDI activity was rapidly stimulated by a single injection of T 3 . Eight hours after T 3 application, 5ЈDI activity was 1.7-fold higher, compared with control, with further increase (2-fold over basal levels) up to 72 h (Fig. 1A) . When the rats received a single injection of 3,5-T2 (800 g/kg BW), 5ЈDI activity also increased, with maximum levels 24 h after application, decreased thereafter, and reached basal levels after 48 h. No difference in the extent of 5ЈDI stimulation was observed after injection of a higher dose 3,5-T2 (1600 g/kg BW), but the time course was slightly delayed (data not shown). Fig. 1B illustrates the dose-response relationship of stimulation of 5ЈDI activity 24 h after injection of T 3 or 3,5-T2 when the maximum effect is observed for 3,5-T2 in vivo. 3,5-T2 seems to be, by a factor of 5-10, less potent than T 3 in 5ЈDI stimulation, but a trend for a dose relationship is visible that, however, does not reach significant levels.
Basal 5ЈDII activity, measured at 10 nm rT 3 substrate concentration in the presence of 1 mm PTU, was an order of magnitude lower than that of 5ЈDI (5ЈDII: 2.4 fmol/mg•min; 5ЈDI: 29.4 fmol/mg⅐min). 5ЈDII activity was rapidly and transiently decreased by T 3 (1.1 fmol/mg⅐min 8 h after a single injection) and the 1600 g/kg BW dose of 3,5-T2 (0.5 fmol/ mg⅐min 8 h after a single injection). Basal levels were reached 24 h after application. 5ЈDII activity was not influenced by the lower doses of 3,5-T2 (data not shown). Pilot analysis of the 5ЈD activities at 2 nm rT 3 substrate concentrations, which tend to underestimate 5ЈDI activity, revealed that 5ЈDII activity is slightly higher under these conditions, but in the same range as with 10 nm rT 3 , whereas absolute specific 5ЈDI activities then are comparable with those of 5ЈDII but still are stimulated by T 3 and 3,5-T2 administration (data not shown).
Effects of 3,5-T2 on 5Јdeiodinase activities in reaggregates of male rat AP
In serum-free reaggregate cell cultures of male rat APs specific 5ЈDI activity was an order of magnitude higher than 5ЈDII activity. Incubation with 3 nm T 3 for 24 h lead to a two-fold stimulation of 5ЈDI activity over basal levels, whereas 5ЈDII activity was no longer detectable. A smaller, but significant, increase in 5ЈDI activity was observed 24 h after incubation with 30 nm 3,5-T2. Again 5ЈDII activity was no longer detectable (Fig. 2) . Incubation with 30 nm 3,5-T2 for 48 h or 72 h lead to a further increase of 5ЈDI activity (2.3-fold over basal levels 48 h and 6-fold over basal levels 72 h after 3, 5-T2 application) (Fig. 3) . Fig. 4 illustrates the stimulation of 5ЈDI in the somatomammotroph rat cell line GH3 after 48 h incubation with T 3 (final concentration 3 nm) and T2 (final concentrations 3, 30, or 300 nm). The activity of the 5ЈDI in cells that were T 3 treated was 1.7-fold higher than control. 3,5-T2 in all concentrations was as potent as T 3 in increasing 5ЈDI activity but did not show a dose response in this concentration range.
Effects of 3,5-T2 on 5ЈDI activity in GH3-cells
Effects of 3,5-T2 on serum TSH-levels
Administration of T 3 rapidly decreased serum TSH levels, with minimum levels 24 h after a single injection. Seventytwo hours after T 3 application, TSH-levels still were significantly lower than control values (Fig. 5A) . TSH-levels were transiently reduced by the application of 800 and 1600 g/kg BW of 3,5-T2, with a nadir 24 h after application and increased thereafter. Basal levels were reached 72 h after a single injection. There was a trend for dose-dependent suppression of TSH by 3,5-T2, which did not reach statistical signigificance, and 3,5-T2 was less potent than T 3 (Fig. 5B) .
Northern analysis
A decrease of ␤TSH steady-state mRNA levels was observed 24 h after a single injection of T 3 . 3,5-T2 also lead to a decrease, but both doses were not as active as T 3 in reducing ␤TSH transcript levels (Fig. 6) . Fig. 7 shows that nuclear extracts of GH3 cells formed three specific protein-DNA complexes with the labeled DRϩ4 oligonucleotide corresponding to the functional TRE in the human 5ЈDI promoter. The shifted bands disappeared completely by the addition of 100-fold excess of unlabeled DRϩ4 oligonucleotide (Fig. 7, lane 9) . This competition for protein-DNA complexes ensures specificity of the interactions. Nuclear extracts of T 3 -treated GH3 cells (3 nm T 3 for 30 min) lead to an increase in the intensity of the retarded bands (Fig. 7 , lane 2), compared with the nuclear extracts of untreated control cells (Fig. 7, lane 1) . A comparable increase was observed using nuclear extracts of cells that were treated with 3 or 30 nm 3,5-T2 (Fig. 7, lanes 3 and 4) . Protein-DNA interactions that occurred using nuclear extracts of untreated control cells, decreased when the cells were cultivated in serum-free medium for another 24 h (Fig. 7, lanes 1 and 5) . Activation of DNA-binding was observed at all tested time points after a single administration of T 3 or 3,5-T2 in both concentrations but also decreased during incubation up to 24 h. The middle band presumably corresponds to a TR␤-RXR heterodimer, as it is supershifted by addition of an RXR antibody (Fig. 7, lane 10) . These binding experiments suggest that functional T 3 -and 3,5-T2-responsive TR-RXR complexes form on the ideal DRϩ4 TRE of the 5ЈDI gene, suggesting transcriptional modulation to be involved in thyroid hormone-dependent expression of 5ЈDI in rat pituitary cells.
EMSA
Discussion
In the pituitary gland of euthyroid rats, half of the T 3 bound to the specific nuclear receptors TR␤ 2 (13) originates from local, intrapituitary T 4 -to-T 3 conversion (7) . Recently, we demonstrated that the type 1 5Јdeiodinase is expressed in the AP of euthyroid rats and is rapidly induced by T 3 (17) . These findings imply that 5ЈDI may play an important function in the pituitary feedback mechanisms of thyroid hormone-dependent gene expression, including TSH synthesis and secretion and, subsequently, also in controlling circulating thyroid hormone levels.
Horst et al. (12) recently reported that a long-term administration of 3,5-T2, the 5Ј-deiodination product of T 3 , exerts suppressive action on TSH secretion without other apparent thyromimetic effects, and Everts et al. (25) demonstrated that 3,5-T2, at concentrations as low as 1 nm, significantly reduced TSH-response to TRH in rat AP cells cultured in monolayer but was 100-fold less effective than T 3 . 3,3Ј-T2, the common metabolite of rT 3 -5Ј-and 5-deiodination, showed no inhibitory effect at that low concentration.
In this study, we present experimental evidence that 3,5-T2 exerts effects on both 5Јdeiodinase activities directly at the pituitary level. In vivo, as well as in vitro, 3,5-T2 stimulates 5ЈDI activity and transiently reduces 5ЈDII activity. The doses of 3,5-T2 for the in vivo experiments were chosen according to the experiments of Horst et al. (12) . Our findings support the observation that doses of 3,5-T2 5-to 10-fold higher than those of T 3 are needed in vivo to exert the same effects at the pituitary level. One possible explanation would be that, in the intact rat, 3,5-T2 is more rapidly and effectively inactivated than T 3 . This explanation is supported by the different time courses and the dose-dependent effects of 3,5-T2 and T 3 in vivo in rat AP reaggregates and GH3 cells using either pituitary 5ЈDI and 5ЈDII, serum TSH, or TSH␤-mRNA as endpoints, respectively. Whereas T 3 and 3,5-T2 seem equipotent in 5ЈDI stimulation in the GH3 model, 3,5-T2 only transiently decreases TSH␤ mRNA steady-state levels and supresses serum TSH, independent of the dose administered in vivo. Similar potencies of T 3 and 3,5-T2 in 5ЈDI stimulation in vitro in the GH3 model suggest at least a partial contribution of a mechanism of action mediated by nuclear T 3 -receptors, as supported by the rapid activation of binding of nuclear transcription factors to the DRϩ4 functional TRE of the human 5ЈDI promoter. The difference in transient 5ЈDII suppression and prolonged 5ЈDI stimulation, both by T 3 and 3,5-T2, were expected to be caused by the different half-lifes and the divergent mechanism of modulation of both deiodinase enzymes (6, 26) . Previous analyses of serum binding, production, and metabolic clearance rates of 3,5-T2, compared with T 3 , suggested a shorter half-life for 3,5-T2 in human serum (27) (28) (29) (30) . An even more rapid metabolism of 3,5-T2 in the normal rat, which has very low circulating TBG levels compared with human serum, might prevent accumulation of nuclear T 3 receptor saturating concentrations of 3,5-T2 required for prolonged and persistent TSH suppression, in contrast to T 3 . No information is yet available for kinetic parameters of 3,5-T2 in the rat. Early studies on comparisons of thyromimetic potencies of rather impure preparations of 3,5-T2 vs. T 4 indicated that in euthyroid animal models, 3,5-T2 exhibits 1/10 to 1/40 of the activity of T 4 , whereas in thyroidectomized rats and human myxedema, 3,5-T2 is less potent than T 4 by more than two orders of magnitude (31) .
Currently, it remains unclear whether the effects of 3,5-T2 are mediated by nuclear T 3 receptors or involve nonnuclear receptor-mediated direct mechanisms at the cell membrane, mitochondrial, or cytoskeletal level, as recently summarized (32) . Some of our data presented here suggest at least a participation of activation of nuclear T 3 /RXR-receptor heterodimers in the mediation of 3,5-T2 effects at the pituitary level, but contribution of other mechanisms cannot be excluded. T 3 stimulates 5ЈDI gene transcription in pituitary GH4C1 cells by a mechanism not requiring ongoing protein synthesis, whereas T 3 effects on GH-mRNA synthesis are blocked by cycloheximide (33) . The inhibitory effect of T 3 on TSH synthesis is directly related to the saturation of nuclear T 3 receptors (34), and for this response, no ongoing or de novo protein synthesis is needed (35) . These results indicate, that T 3 can modulate gene transcription in the AP by at least two different mechanisms. In GH3 cells, 3,5-T2 is capable of regulating GH and TR␤ 2 gene expression and can bind to in vitro translated TRs (36) . With EMSAs, we demonstrated, that 3,5-T2 rapidly activates proteins that can specifically bind to the DRϩ4 TRE that was identified in the promoter region of the human 5ЈDI gene (22) . 3,5-T2 was as potent as T 3 in stimulating DNA-protein interactions. One of the retarded bands presumably represents a TR␤ 2 -RXR heterodimer, because it is supershifted by the addition of a RXR antibody. The exact mechanism of T 3 or 3,5-T2-dependent recruitment or increased DRϩ4-binding of nuclear transcription factors, such as RXRs or other DNA-binding proteins, remains to be analyzed. Ligand-dependent stabilization of protein-DNA interactions, removal of corepressors, and/or nuclear translocation of receptors might contribute to this increased binding. Whether 3,5-T2 exerts its effects on T 3 -dependent genes in the AP directly by binding and activating TRs and interacting with TREs in the promoter regions of these genes or indirectly by stimulation of 5ЈDI activity and consequently leading to higher intrapituitary T 3 production, remains to be evaluated. The demonstration of both 5ЈDI and 5ЈDII activity in somatomammotroph GH3 cells, responsive to T 3 and its potential 5Ј-deiodination product 3,5-T2, also raises the possibility that local auto-and paracrine interactions between the more abundant somatotrophes, generating T 3 and/or 3,5-T2, and thyrotrophes, responsive to these thyroid hormones, in the TSH-feedback system seems possible and needs to be studied in more detail.
